Interview (BASF): Sustainable growth makes Asia Pacific the largest global market
Published: 9 May 2018
In this episode in Agrow’s new series of podcasts, Sanjiv Rana talks to Gustavo Palerosi Carneiro, BASF Crop Protection’s senior vice-president, Asia Pacific, based in Singapore. The interview was conducted at BASF’s office in Tokyo, Japan.
Mr Carneiro discusses factors affecting the crop protection market in the Asia Pacific region. Having previously worked for BASF in Latin America, he provides interesting insights while comparing the two markets as he identifies factors leading to more sustainable growth in the Asia Pacific region. Larger diversification of crops within the latter region with less dependence on the international prices of row crops makes growth in the region more sustainable.
Mr Carneiro also talks about markets that he considers key within the region and regulatory hurdles in certain markets that face the crop protection industry. He highlights China with having huge potential due to its economic growth and greater demand of quality food by consumers. The consolidation of farming area will also lead to growth.
Talking about new active ingredients, he says that BASF will launch six new ais within the next five years resulting in more than 100 new products. The new ais include the insecticide, afidopyropen (trade-marked as Inscalis), which was discovered in a research collaboration between Japanese company Meiji Seika Pharma and the Japanese Kitasato Institute. It received its first global registration in Australia last month. BASF plans to launch the ai in India and Australia this year.
Other new ais include the fungicide, mefentrifluconazole (trade-marked as Revysol). The company plans to launch it in Korea and Australia in 2019.
You can listen to the podcast here:
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.